Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Low Dose Colchicine on Platelet Reactivity in Chronic Coronary Disease
NCT05956145Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2021
- Primary completion
- Apr 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of colchicine in coronary artery disease (CAD) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Platelet aggregation to TRAP at 30 days. Started Jun 2021; status: completed.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05956145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05956145.